Bioceres Crop Solutions Corp. (NASDAQ:BIOX) reported Q4 EPS of ~$0.07, versus the analyst estimate of $0.20. Revenue for the quarter came in at $104.1 million versus the consensus estimate of $94.89 million.
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) reported Q4 EPS of ~$0.07, versus the analyst estimate of $0.20. Revenue for the quarter came in at $104.1 million versus the consensus estimate of $94.89 million.